Epinephrine for First-aid Management of Anaphylaxis
- 1 March 2017
- journal article
- practice guideline
- Published by American Academy of Pediatrics (AAP)
- Vol. 139 (3), e20164006
- https://doi.org/10.1542/peds.2016-4006
Abstract
Anaphylaxis is a severe, generalized allergic or hypersensitivity reaction that is rapid in onset and may cause death. Epinephrine (adrenaline) can be life-saving when administered as rapidly as possible once anaphylaxis is recognized. This clinical report from the American Academy of Pediatrics is an update of the 2007 clinical report on this topic. It provides information to help clinicians identify patients at risk of anaphylaxis and new information about epinephrine and epinephrine autoinjectors (EAs). The report also highlights the importance of patient and family education about the recognition and management of anaphylaxis in the community. Key points emphasized include the following: (1) validated clinical criteria are available to facilitate prompt diagnosis of anaphylaxis; (2) prompt intramuscular epinephrine injection in the mid-outer thigh reduces hospitalizations, morbidity, and mortality; (3) prescribing EAs facilitates timely epinephrine injection in community settings for patients with a history of anaphylaxis and, if specific circumstances warrant, for some high-risk patients who have not previously experienced anaphylaxis; (4) prescribing epinephrine for infants and young children weighing <15 kg, especially those who weigh 7.5 kg and under, currently presents a dilemma, because the lowest dose available in EAs, 0.15 mg, is a high dose for many infants and some young children; (5) effective management of anaphylaxis in the community requires a comprehensive approach involving children, families, preschools, schools, camps, and sports organizations; and (6) prevention of anaphylaxis recurrences involves confirmation of the trigger, discussion of specific allergen avoidance, allergen immunotherapy (eg, with stinging insect venom, if relevant), and a written, personalized anaphylaxis emergency action plan; and (7) the management of anaphylaxis also involves education of children and supervising adults about anaphylaxis recognition and first-aid treatment.Keywords
This publication has 62 references indexed in Scilit:
- Prospective Evaluation of an Anaphylaxis Education Mini-Handout: The AAAAI Anaphylaxis Wallet CardThe Journal of Allergy and Clinical Immunology: In Practice, 2013
- Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxisJournal of Allergy and Clinical Immunology, 2012
- Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspectiveAnnals of Allergy, Asthma & Immunology, 2012
- Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patientsJournal of Allergy and Clinical Immunology, 2012
- Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactionsJournal of Allergy and Clinical Immunology, 2011
- Anaphylaxis in a New York City pediatric emergency department: Triggers, treatments, and outcomesJournal of Allergy and Clinical Immunology, 2011
- World Allergy Organization anaphylaxis guidelines: SummaryJournal of Allergy and Clinical Immunology, 2011
- Age-Related Differences in the Clinical Presentation of Food-Induced AnaphylaxisThe Journal of Pediatrics, 2011
- Epinephrine and its use in anaphylaxis: current issuesCurrent Opinion in Allergy and Clinical Immunology, 2010
- H1‐antihistamines for the treatment of anaphylaxis: Cochrane systematic reviewAllergy, 2007